AMY ALBRECHT: Open Payments
NPI 1568895993 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 56 payments from 21 companies in 2025. Trend: 2023 $333 · 2024 $787 · 2025 $1,213
Food & beverage: $1,120Education: $93
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $176 |
| Novartis Pharmaceuticals Corporation | 8 | $170 |
| Janssen Biotech, Inc. | 4 | $158 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Eisai Inc. | 4 | $83 |
| ABBVIE INC. | 2 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| ARRAY BIOPHARMA INC | 3 | $47 |
| SpringWorks Therapeutics, Inc. | 1 | $46 |
| Gilead Sciences, Inc. | 2 | $44 |
Products named: DARZALEX, Lenvima, KISQALI, IMBRUVICA, XTANDI, SCEMBLIX, XALKORI, IBRANCE.
Industry payments across OH — which companies pay providers there.
